Pathway-Targeted Pharmacogenomics of CYP1A2 in Human Liver

@inproceedings{Klein2010PathwayTargetedPO,
  title={Pathway-Targeted Pharmacogenomics of CYP1A2 in Human Liver},
  author={Kathrin E Klein and Stefan Winter and Miia Turpeinen and Matthias Schwab and Ulrich M. Zanger},
  booktitle={Front. Pharmacol.},
  year={2010}
}
The human drug metabolizing cytochrome P450 (CYP) 1A2, is one of the major P450 isoforms contributing by about 5-20% to the hepatic P450 pool and catalyzing oxidative biotransformation of up to 10% of clinically relevant drugs including clozapine and caffeine. CYP1A2 activity is interindividually highly variable and although twin studies have suggested a high heritability, underlying genetic factors are still unknown. Here we adopted a pathway-oriented approach using a large human liver bank (n… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 27 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 105 references

Association of aryl hydrocarbon receptor gene polymorphisms and urinary 1-hydroxypyrene in polycyclic aromatic hydrocarbon-exposed workers.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology • 2008
View 6 Excerpts
Highly Influenced

Sex-specific differences in CYP450 isoforms in humans.

Expert opinion on drug metabolism & toxicology • 2008
View 10 Excerpts
Highly Influenced

Vitamin D receptor gene

B K.
2007
View 12 Excerpts
Highly Influenced

Ah receptor and NF-kappaB interplay on the stage of epigenome.

Biochemical pharmacology • 2009
View 5 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…